BAXTER INTERNATIONAL INC. Deferred Revenue Recognized
BAXTER INTERNATIONAL INC. (BAX) reported Deferred Revenue Recognized of $90.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $46.00M, a 35.29% increase year-over-year.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $34.00M, a 20.93% decline year-over-year.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $43.00M, a 33.85% decline year-over-year.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $65.00M, a 30.00% increase year-over-year.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for fiscal 2025 was $115.00M, a 11.65% increase from fiscal 2024.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for fiscal 2024 was $103.00M, a 11.97% decline from fiscal 2023.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for fiscal 2023 was $117.00M, a 1.74% increase from fiscal 2022.
- BAXTER INTERNATIONAL INC. contract with customer, liability, revenue recognized for fiscal 2022 was $115.00M, a 4.55% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $90.00M 10-Q · filed 2026-07-30 | |||||||
| 2026-03-31 | $46.00M 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | $115.00M 10-K · filed 2026-02-12 | |||||||
| 2025-09-30 | $89.00M 10-Q · filed 2025-11-04 | |||||||
| 2025-06-30 | $57.00M 10-Q · filed 2026-07-30 | |||||||
| 2025-03-31 | $34.00M 10-Q · filed 2026-04-30 | |||||||
| 2024-12-31 | $103.00M 10-K · filed 2026-02-12 | |||||||
| 2024-09-30 | $94.00M 10-Q · filed 2025-11-04 | |||||||
| 2024-06-30 | $73.00M 10-Q · filed 2025-08-05 | $80.00M 10-Q · filed 2024-08-06 | ||||||
| 2024-03-31 | $43.00M 10-Q · filed 2025-05-06 | $48.00M 10-Q · filed 2024-05-02 | ||||||
| 2023-12-31 | $117.00M 10-K · filed 2026-02-12 | $127.00M 10-K · filed 2024-02-08 | ||||||
| 2023-09-30 | $111.00M 10-Q · filed 2024-11-12 | $119.00M 10-Q · filed 2023-11-02 | ||||||
| 2023-06-30 | $64.00M 10-Q · filed 2024-08-06 | |||||||
| 2023-03-31 | $65.00M 10-Q · filed 2024-05-02 | $68.00M 10-Q · filed 2023-04-27 | ||||||
| 2022-12-31 | $115.00M 10-K · filed 2024-02-08 | $121.00M 10-K · filed 2023-02-09 | ||||||
| 2022-09-30 | $99.00M 10-Q · filed 2023-11-02 | |||||||
| 2022-06-30 | $77.00M 10-Q · filed 2023-07-27 | |||||||
| 2022-03-31 | $50.00M 10-Q · filed 2023-04-27 | $122.00M 10-Q · filed 2022-04-28 | ||||||
| 2021-12-31 | $110.00M 10-K · filed 2025-02-21 | $20.00M 10-K · filed 2022-02-23 | ||||||
| 2020-12-31 | $17.00M 10-K · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |